June 2025

Pharma Courses 
PAGE Admission
Applications are invited for Project Coordinator at MCC
26 June 2025

Applications are invited for Project Coordinator at MCC - Life Sciences Apply

Masters degree in a relevant field of Life Sciences, Clinical research, Nursing. experience in Clinical trial Pharma sponsored, Investigator initiated or Research funded project.
26 June 2025
Walk in Drive for M.Pharm in Formulation Development Department at Sun Pharma
Execution of scale up, exhibit batches, characterization batches, process validation batches and commercial batches at manufacturing locations.
26 June 2025
Zydus Lifesciences Interview for Vaccine Technology Center at Pune
Post-Graduate M.Sc. in Biochemistry, Biotechnology, Microbiology, Life sciences.1-6 years of hands-on experience in relevant field, preferred Vaccine, Biotech background.
26 June 2025
Interview for D.Pharm, B.Pharm, M.Pharm in Production, IPQA at Ipca Laboratories
Experience In operation and supervision of Compression, Granulation & Coating machine I.e. Fette, Glatt, Ganson, Imprinting etc.
26 June 2025
Amneal Pharma Hiring B.Pharm in OSD regulated plant
Looking for candidates with relevant experience in OSD regulated plant. RMG, FBE,FETTE, Auto coaters, Bottle Packing line with track and trace systems.
26 June 2025
Interview for M.Pharm, MSc as Trainee at Biophore
Conduct Experiments and Write Laboratory Notebooks Good Academic knowledge and Communication skills
26 June 2025
Eli Lilly Launches Mounjaro KwikPen in India to Rival Novo Nordisk Wegovy
As reported by Reuters, U.S. pharmaceutical giant Eli Lilly has launched its Mounjaro KwikPen in India, expanding its portfolio of treatments for diabetes and obesity.
26 June 2025
Lupin Launches Generic Prucalopride Tablets in U.S. for Chronic Constipation Treatment

Lupin Limited, a leading global pharmaceutical company, has announced the launch of its Prucalopride Tablets in 1 mg and 2 mg strengths in the United States, following the recent approval of its Abbreviated New Drug Application (ANDA) by the U.S. Food and Drug Administration (FDA). 

26 June 2025
Sanofi’s Riliprubart earns USFDA orphan drug designation for organ transplant complication
In a promising development for transplant medicine, global healthcare leader Sanofi has announced that its investigational therapy riliprubart has received Orphan Drug Designation from the U.S. Food and Drug Administration.
26 June 2025
UCSD develops gene therapy that preserves memory in Alzheimer’s mouse models
A pioneering gene therapy engineered by researchers at the University of California San Diego (UCSD) School of Medicine demonstrates remarkable promise in halting, and potentially reversing, cognitive decline in preclinical Alzheimer’s models.